Matches in SemOpenAlex for { <https://semopenalex.org/work/W2531691490> ?p ?o ?g. }
- W2531691490 abstract "Abstract Background Artemisinins are primarily responsible for initial parasite clearance. Antimalarial pharmacokinetics (PK), human immunodeficiency virus (HIV) infection, and antiretroviral therapy have been shown to impact treatment outcomes, although their impact on early parasite clearance in children has not been well characterized. Methods Parasite clearance parameters were generated from twice-daily blood smears in HIV-infected and HIV-uninfected Ugandan children treated with artemether-lumefantrine (AL). Artemether and dihydroartemisinin (DHA) area-under-the-curve from 0–8 hours (AUC0-8hr) after the 1st AL dose was compared with AUC0-8hr after the last (6th) dose in a concurrently enrolled cohort. The association between post-1st dose artemisinin AUC0-8hr and parasite clearance was assessed. Results Parasite clearance was longer in HIV-infected versus HIV-uninfected children (median, 3.5 vs 2.8 hours; P = .003). Artemether AUC0-8hr was 3- to 4-fold lower after the 6th dose versus the 1st dose of AL in HIV-infected children on nevirapine- or lopinavir/ritionavir-based regimens and in HIV-uninfected children (P ≤ .002, 1st vs 6th-dose comparisons). Children on efavirenz exhibited combined post-1st dose artemether/DHA exposure that was significantly lower than those on lopinavir/ritonavir and HIV-uninfected children. Multiple regression analysis supported that the effect of artemether/DHA exposure on parasite clearance was significantly moderated by HIV status. Conclusions Parasite clearance rates remain rapid in Uganda and were not found to associate with PK exposure. However, significant decreases in artemisinin PK with repeated dosing in nearly all children, coupled with small, but significant increase in parasite clearance half-life in those with HIV, may have important implications for AL efficacy, particularly because reports of artemisinin resistance are increasing." @default.
- W2531691490 created "2016-10-21" @default.
- W2531691490 creator A5016442598 @default.
- W2531691490 creator A5018167758 @default.
- W2531691490 creator A5041011585 @default.
- W2531691490 creator A5046964962 @default.
- W2531691490 creator A5051266311 @default.
- W2531691490 creator A5063298724 @default.
- W2531691490 creator A5065697342 @default.
- W2531691490 creator A5068107662 @default.
- W2531691490 creator A5074557677 @default.
- W2531691490 creator A5076124051 @default.
- W2531691490 creator A5089282370 @default.
- W2531691490 creator A5089323165 @default.
- W2531691490 date "2016-01-01" @default.
- W2531691490 modified "2023-10-17" @default.
- W2531691490 title "Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children" @default.
- W2531691490 cites W1527428657 @default.
- W2531691490 cites W1692234463 @default.
- W2531691490 cites W1921967810 @default.
- W2531691490 cites W1945105808 @default.
- W2531691490 cites W1972128519 @default.
- W2531691490 cites W1990770244 @default.
- W2531691490 cites W2003399176 @default.
- W2531691490 cites W2007933951 @default.
- W2531691490 cites W2020465799 @default.
- W2531691490 cites W2046415190 @default.
- W2531691490 cites W2051387171 @default.
- W2531691490 cites W2064045631 @default.
- W2531691490 cites W2067311491 @default.
- W2531691490 cites W2096407013 @default.
- W2531691490 cites W2099534544 @default.
- W2531691490 cites W2103049577 @default.
- W2531691490 cites W2104700616 @default.
- W2531691490 cites W2114496951 @default.
- W2531691490 cites W2118868447 @default.
- W2531691490 cites W2119156545 @default.
- W2531691490 cites W2122167407 @default.
- W2531691490 cites W2124634096 @default.
- W2531691490 cites W2136730020 @default.
- W2531691490 cites W2138717517 @default.
- W2531691490 cites W2139324809 @default.
- W2531691490 cites W2139622114 @default.
- W2531691490 cites W2148068300 @default.
- W2531691490 cites W2153305121 @default.
- W2531691490 cites W2154021375 @default.
- W2531691490 cites W2161311583 @default.
- W2531691490 cites W2166143794 @default.
- W2531691490 cites W2168987526 @default.
- W2531691490 cites W2171102256 @default.
- W2531691490 cites W2281124395 @default.
- W2531691490 cites W2307004889 @default.
- W2531691490 cites W2345811532 @default.
- W2531691490 doi "https://doi.org/10.1093/ofid/ofw217" @default.
- W2531691490 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5170492" @default.
- W2531691490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28018925" @default.
- W2531691490 hasPublicationYear "2016" @default.
- W2531691490 type Work @default.
- W2531691490 sameAs 2531691490 @default.
- W2531691490 citedByCount "6" @default.
- W2531691490 countsByYear W25316914902017 @default.
- W2531691490 countsByYear W25316914902018 @default.
- W2531691490 countsByYear W25316914902019 @default.
- W2531691490 countsByYear W25316914902022 @default.
- W2531691490 crossrefType "journal-article" @default.
- W2531691490 hasAuthorship W2531691490A5016442598 @default.
- W2531691490 hasAuthorship W2531691490A5018167758 @default.
- W2531691490 hasAuthorship W2531691490A5041011585 @default.
- W2531691490 hasAuthorship W2531691490A5046964962 @default.
- W2531691490 hasAuthorship W2531691490A5051266311 @default.
- W2531691490 hasAuthorship W2531691490A5063298724 @default.
- W2531691490 hasAuthorship W2531691490A5065697342 @default.
- W2531691490 hasAuthorship W2531691490A5068107662 @default.
- W2531691490 hasAuthorship W2531691490A5074557677 @default.
- W2531691490 hasAuthorship W2531691490A5076124051 @default.
- W2531691490 hasAuthorship W2531691490A5089282370 @default.
- W2531691490 hasAuthorship W2531691490A5089323165 @default.
- W2531691490 hasBestOaLocation W25316914901 @default.
- W2531691490 hasConcept C112705442 @default.
- W2531691490 hasConcept C142462285 @default.
- W2531691490 hasConcept C159047783 @default.
- W2531691490 hasConcept C203014093 @default.
- W2531691490 hasConcept C2776120307 @default.
- W2531691490 hasConcept C2777182164 @default.
- W2531691490 hasConcept C2777288759 @default.
- W2531691490 hasConcept C2778048844 @default.
- W2531691490 hasConcept C2778118209 @default.
- W2531691490 hasConcept C2778371730 @default.
- W2531691490 hasConcept C2778629330 @default.
- W2531691490 hasConcept C2779130552 @default.
- W2531691490 hasConcept C2779298103 @default.
- W2531691490 hasConcept C2780780316 @default.
- W2531691490 hasConcept C2781160685 @default.
- W2531691490 hasConcept C2781432083 @default.
- W2531691490 hasConcept C2993143319 @default.
- W2531691490 hasConcept C3013748606 @default.
- W2531691490 hasConcept C71924100 @default.
- W2531691490 hasConcept C98274493 @default.
- W2531691490 hasConceptScore W2531691490C112705442 @default.
- W2531691490 hasConceptScore W2531691490C142462285 @default.